Dernières nouvelles
Information non disponible
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk
Article de revueClin Infect Dis, 78 (2), 2024.
Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study
Article de revueClin Infect Dis, 78 (3), 2024.
Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay
Article de revueMicrobiol Spectr, 12 (6), 2024.
Treatment of severe human mpox virus infection with tecovirimat: A case series
Article de revueCan Commun Dis Rep, 49 (2-3), 2023.
Evaluation of Real-life Use of Point-of-care Rapid Antigen Testing for SARS-CoV-2 in Schools (EPOCRATES): a cohort study
Article de revueCMAJ Open, 10 (4), 2022.
The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing
Article de revueCan Commun Dis Rep, 47 (12), 2021.
Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)
Article de revueJ Clin Virol, 144 , 2021.
Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing Enterobacterales Using Time-Kill Assays
Article de revueAntimicrob Agents Chemother, 65 (4), 2021.
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
Article de revueDiagn Microbiol Infect Dis, 101 (3), 2021.
Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study
Article de revueClin Infect Dis, 70 (10), 2020.
Projets terminés récemment
- Prédire l'évolution de l'hépatite C par la fédération de données et l'intelligence artificielle : enjeux éthiques, juridiques, sociaux et de vie privée, du 2019-04-01 au 2024-03-31